Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial

BACKGROUND AND AIMS: Mucosal healing [MH] is an important goal for patients with Crohn’s disease [CD], yet is incompletely characterised. We investigated whether MH differed by segments across the colon and ileum in patients who received adalimumab maintenance treatment in the EXTEND study. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinisch, Walter, Colombel, Jean-Frédéric, D’Haens, Geert, Sandborn, William J., Rutgeerts, Paul, Geboes, Karel, Petersson, Joel, Eichner, Samantha, Zhou, Qian, Robinson, Anne M., Read, Holly A., Thakkar, Roopal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881717/
https://www.ncbi.nlm.nih.gov/pubmed/27815351
http://dx.doi.org/10.1093/ecco-jcc/jjw178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881717/
https://www.ncbi.nlm.nih.gov/pubmed/27815351
http://dx.doi.org/10.1093/ecco-jcc/jjw178

Ejemplares similares